Search
Products
Community
Markets
News
Brokers
More
IN
Get started
Markets
/
Switzerland
/
ETF market
/
NBTK
/
Analysis
INVESCO MARKETS PL
NBTK
BX Swiss
NBTK
BX Swiss
NBTK
BX Swiss
NBTK
BX Swiss
Market closed
Market closed
No trades
See on Supercharts
Overview
Analysis
Discussions
Technicals
Seasonals
Key stats
Assets under management (AUM)
257.11 M
CHF
Fund flows (1Y)
−249.80 M
CHF
Dividend yield (indicated)
—
Discount/Premium to NAV
−0.6%
Shares outstanding
5.75 M
Expense ratio
0.40%
About INVESCO MARKETS PL
Issuer
Invesco Ltd.
Brand
Invesco
Home page
etf.invesco.com
Inception date
Nov 7, 2014
Structure
Irish VCIC
Index tracked
NASDAQ / Biotechnology
Replication method
Synthetic
Management style
Passive
ISIN
IE00BQ70R696
The Fund is a passively managed Exchange-Traded Fund (ETF), which aims to track the Total Return performance of the NASDAQ Biotechnology Index (the Index) 1, less fees, expenses and transaction costs.
Show more
Classification
Asset Class
Equity
Category
Sector
Focus
Health care
Niche
Biotechnology
Strategy
Exchange-specific
Geography
U.S.
Weighting scheme
Market cap
Selection criteria
NASDAQ - listed
Returns
1 month
3 months
Year to date
1 year
3 years
5 years
Price performance
—
—
—
—
—
—
NAV total return
—
—
—
—
—
—
What's in the fund
As of January 16, 2025
Exposure type
Stocks
Bonds, Cash & Other
Health Technology
Stocks
99.99%
Health Technology
97.55%
Commercial Services
1.38%
Technology Services
0.53%
Health Services
0.50%
Process Industries
0.04%
Bonds, Cash & Other
0.01%
Miscellaneous
0.01%
Cash
0.00%
Stock breakdown by region
99%
0.2%
North America
99.79%
Europe
0.21%
Latin America
0.00%
Asia
0.00%
Africa
0.00%
Middle East
0.00%
Oceania
0.00%
Top 10 holdings
Dividends
Dividend payout history
Assets under management (AUM)
Fund Flows